New MRI Imaging Provides Better Diagnosing For Prostate Cancer
The diagnostic methods for prostate cancer usually may begin with testing for the elevated level of the Prostate Specific Antigen (PSA)in the blood stream.
If there is a spike, then it is likely that the individual has prostate cancer and tissue biopsies usually follow to stage the cancer. However, these diagnostics procedures are limited in the accuracy of results they give.
More so, the man could be subjected to painful needle insertions and sometimes there are no clear definitive boundaries for the tumor.
A new Magnetic Resonant Imaging technique developed in the Netherlands is said to take care of the shortcomings of the PSA and Biopsy screening. This MRI imaging is advocated created by Dr. Jelle Barentsz, a urogenital disease specialist in the Netherlands. The new technology is approved by Dr. David Samadi, a top US prostate cancer surgeon.
The following is an extract on this new MRI imaging that is expected to provide better and precise diagnosing of prostate cancer:
More precise prostate cancer diagnostics could be right around the corner, thanks to evolving MRI capabilities. Netherlands MRI and Urogenital disease specialist, Dr. Jelle Barentsz, is making significant headway in improving MRI technology to accurately diagnose and stage prostate cancer tumors with a success rate of 90 percent.
Detected through a simple blood test, a spike in PSA level is typically the first indicator of the potential presence of prostate cancer. A prostate cancer biopsy is then performed through a series of 12, sometimes painful, needle insertions. Despite these procedures, current prostate cancer staging abilities are somewhat limited and the needle biopsies do not always clearly define the tumor’s boundaries.
Dr. David Samadi, leading U.S. prostate cancer surgeon, details how Dr. Barentsz’s MRI advancements could significantly improve the ability to accurately define the degree of a man’s prostate cancer. “With current diagnostics I don’t get a perfect picture of the prostate cancer until I see it first-hand during robotic prostate surgery. The microscopic clarity of Dr. Barentsz’s new MRI technology may soon afford the opportunity to truly see the prostate, the cancer, and its borders before surgery is performed,” Dr. Samadi explained.
More accurate MRI imaging has the potential to improve prostate cancer diagnosis in two major ways. First, needle biopsy could be reduced to one or two highly targeted insertions based on exact imaging of the tumor location. Second, more precise imaging could reduce the need for biopsy in men where no prostate abnormalities are visualized.
Some critics argue that routine PSA screening leads to unnecessary biopsies as not all elevated PSA levels are caused by prostate cancer. Dr. Barentsz believes prostate cancer biopsies could be reduced by as much as two-thirds with his more accurate imaging.
At the end of 2011, Dr. Samadi traveled to the Netherlands to work side-by-side with Dr. Barentsz at The Dutch Radboud University Nijmegen Medical Center. During his stay, Dr. Samadi performed multiple, live robotic prostatectomy surgeries to train local experts on his custom Samadi Modified Advanced Robotic Technique (SMART) surgery.
“While in the Netherlands I witnessed the exciting potential of Dr. Barentsz’s advanced MRI imaging,” Dr. Samadi said. “We were able to combine the power of his technology with the precision of my SMART surgery to yield very successful results. I truly believe that his efforts will have a great impact on the ability to diagnose and eliminate prostate cancer for patients globally.”
Dr. David Samadi is Vice Chairman of the Department of Urology and Chief of Robotics and Minimally Invasive Surgery at Mount Sinai Medical Center. From his practice in New York City, Dr. Samadi often travels overseas to “treat and teach” his SMART surgery procedure and routinely welcomes international patients for surgery in the U.S. To date, over 4,000 men have benefited from the life-saving results of his skilled prostate removal surgery. Source.
So, it is important that we get to know that this new MRI imaging is a breakthrough diagnostic method for prostate cancer. Dr. Samadi is a surgeon who has many of experience in treating prostate cancer. His recommendation for this new diagnostic procedure is therefore coming from someone who has seen it all.
The MRI imaging can help to reduce unnecessary painful needle insertions, and eliminate the need for biopsies where there are no traces of prostate abnormalities.
Conclusively, the new imaging may help provide better diagnosis and treatments which may eventually reduce the risk of deaths for prostate cancer victims.
This HUGE 4+ Year Old Prostate Cancer Victory Authority Website:
(95% of these 1,000+ Prostate Cancer Articles on this website
are written by our Expert In -house Writers, after lots of research.
The remaining 5% are news articles and videos from relevant sources!)
- MRI and Prostate Cancer Testing
- Advanced MRI Technology Provides Reliable Prostate Cancer Detection
- Spectral Imaging Module For Prostate Cancer?
- Prostate Cancer Psa Test – Diagnosing And Staging